By orally administering the vaccine combined with anti-CD3 antibodies to mice with acute and progressive onset of diabetes, we found that 63% of acute and 78% of progressive diabetic mice exhibited lower blood glucose levels, along with a remarkable increase in insulin positive cells after therapy. Here, INS is linked to diabetes mellitus.